Geneos Wealth Management’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $85K | Sell |
5,954
-4,928
| -45% | -$70.4K | ﹤0.01% | 1314 |
|
2025
Q1 | $114K | Buy |
10,882
+6,929
| +175% | +$72.8K | ﹤0.01% | 1496 |
|
2024
Q4 | $47.9K | Sell |
3,953
-71
| -2% | -$860 | ﹤0.01% | 1339 |
|
2024
Q3 | $59.1K | Buy |
4,024
+217
| +6% | +$3.19K | ﹤0.01% | 1139 |
|
2024
Q2 | $54.9K | Sell |
3,807
-530
| -12% | -$7.65K | ﹤0.01% | 1037 |
|
2024
Q1 | $70.6K | Sell |
4,337
-1,134
| -21% | -$18.5K | ﹤0.01% | 957 |
|
2023
Q4 | $81.5K | Sell |
5,471
-6,016
| -52% | -$89.6K | ﹤0.01% | 896 |
|
2023
Q3 | $129K | Sell |
11,487
-6,183
| -35% | -$69.5K | 0.01% | 799 |
|
2023
Q2 | $178K | Sell |
17,670
-5,584
| -24% | -$56.2K | 0.01% | 705 |
|
2023
Q1 | $219K | Sell |
23,254
-5,053
| -18% | -$47.5K | 0.01% | 634 |
|
2022
Q4 | $346K | Buy |
28,307
+7,154
| +34% | +$87.4K | 0.02% | 488 |
|
2022
Q3 | $262K | Buy |
21,153
+8,173
| +63% | +$101K | 0.02% | 540 |
|
2022
Q2 | $267K | Buy |
12,980
+1,103
| +9% | +$22.7K | 0.01% | 649 |
|
2022
Q1 | $309K | Buy |
11,877
+1,972
| +20% | +$51.3K | 0.01% | 658 |
|
2021
Q4 | $281K | Buy |
9,905
+865
| +10% | +$24.5K | 0.01% | 748 |
|
2021
Q3 | $290K | Buy |
9,040
+5,149
| +132% | +$165K | 0.01% | 728 |
|
2021
Q2 | $135K | Buy |
3,891
+639
| +20% | +$22.2K | 0.01% | 1031 |
|
2021
Q1 | $103K | Buy |
+3,252
| New | +$103K | ﹤0.01% | 1297 |
|
2020
Q3 | – | Sell |
-67
| Closed | -$1K | – | 2648 |
|
2020
Q2 | $1K | Sell |
67
-2,894
| -98% | -$43.2K | ﹤0.01% | 2451 |
|
2020
Q1 | $64K | Buy |
2,961
+157
| +6% | +$3.39K | ﹤0.01% | 1021 |
|
2019
Q4 | $82K | Buy |
2,804
+2,737
| +4,085% | +$80K | ﹤0.01% | 1028 |
|
2019
Q3 | $1K | Sell |
67
-1,072
| -94% | -$16K | ﹤0.01% | 2390 |
|
2019
Q2 | $38K | Buy |
1,139
+1,000
| +719% | +$33.4K | ﹤0.01% | 1329 |
|
2019
Q1 | $4K | Buy |
+139
| New | +$4K | ﹤0.01% | 2083 |
|